Roselabs Bioscience Ltd and Roselabs Polymers Ltd is planning to invest Rs. 4000 million to manufacture pre-filled syringes in India. The method of using pre-filled syringe is designed to provide assured sterility, safety, convenience, greater accuracy, minimal over-filling, least medical waste, freedom from needle phobia and least chances of accidental needle stick injuries. The company has the capacity to manufacture 8 lakh syringes daily. Currently, 95% of pre-filled syringes are imported.Latest News :
The company is in the process of raising Rs. 1000 million towards private equity placements and venture capital
|11,950 ₹||4950 ₹||4950 ₹||4950 ₹||3950 ₹|
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony